Downregulation of matrix and β-PDGF receptor gene expression by anti-TGFβ antibody in rat hepatic stellate cells during experimental liver injury

International Hepatology Communications

Volumn 6, Issue 3-4, 1997, Pages 144-152

  Ankoma Sey, Victor ^a   Tzagarakis, Christina ^a   Chang, Kun Bee ^a   Friedman, Scott L ^a  

^a SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

cytokines; extracellular matrix; fibronectin; hepatic fibrosis

Indexed keywords

COLLAGEN TYPE 1; FIBRONECTIN; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FIBROGENESIS; LIVER FIBROSIS; LIVER INJURY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION; STELLATE CELL;

EID: 0031048333     PISSN: 09284346     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-4346(96)00341-6     Document Type: Article

References (36)

1. [1] Friedman SL. Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med 1993; 328(25): 1828-1835.
2. [2] Border WA. Transforming growth factor-beta and the pathogenesis of glomerular diseases. Curr Opin Nephrol Hypertens 1994; 3(1): 54-58.
3. [3] Pierce GF, Mustoe TA, Lingelbach J, et al. Platelet-derived growth factor and transforming growth factor-beta enhance tissue repair activities by unique mechanisms. J Cell Biol 1989; 109(1): 429-440.
4. [4] Weiner FR, Shah A, Biempica L, Zern MA, Czaja MJ. The effects of hepatic fibrosis on Ito cell gene expression. Matrix 1992; 12(1): 36-43.
5. [5] Milani S, Herbst H, Schuppan D, Stein H, Surrenti C. Transforming growth factors beta 1 and beta 2 are differentially expressed in fibrotic liver disease. Am J Pathol 1991; 139(6): 1221-1229.
6. [6] Bissell DM, Wang SS, Jarnagin WR, Roll FJ. Cell-specific expression of transforming growth factor-beta in rat liver. Evidence for autocrine regulation of hepatocyte proliferation. J Clin Invest 1995; 96(1): 447-455.
7. [7] Matsuoka M, Tsukamoto H. Stimulation of hepatic lipocyte collagen production by Kupffer cell-derived transforming growth factor beta: implication for a pathogenetic role in alcoholic liver fibrogenesis. Hepatology 1990; 11(4): 599-605.
8. [8] Castilla A, Prieto J, Fausto N. Transforming growth factors beta 1 and alpha in chronic liver disease. Effects of interferon alfa therapy. N Engl J Med 1991; 324(14): 933-940.
9. [9] Friedman SL, Yamasaki G, Wong L. Modulation of transforming growth factor beta receptors of rat lipocytes during the hepatic wound healing response. Enhanced binding and reduced gene expression accompany cellular activation in culture and in vivo. J Biol Chem 1994; 269(14): 10551-10558.
10. [10] de Bleser PJ, Jannes P, van Buul-Offers SC, et al. Insulinlike growth factor-II/mannose 6-phosphate receptor is expressed on CC14-exposed rat fat-storing cells and facilitates activation of latent transforming growth factor-beta in cocultures with sinusoidal endothelial cells. Hepatology 1995; 21(5): 1429-1437.
11. [11] Ramadori G, Knittel T, Odenthal M, Schwogler S, Neubauer K, Meyer zum Buschenfelde KH. Synthesis of cellular fibronectin by rat liver fat-storing (Ito) cells: regulation by cytokines. Gastroenterol 1992; 103(4): 1313-1321.
12. [12] Matsuoka M, Pham NT, Tsukamoto H. Differential effects of interleukin-1 alpha, tumor necrosis factor alpha, and transforming growth factor beta 1 on cell proliferation and collagen formation by cultured fat-storing cells. Liver 1989; 9(2): 71-78.
13. [13] Bachem MG, Riess U, Melchior R, Sell KM, Gressner AM. Transforming growth factors (TGF alpha and TGF beta 1) stimulate chondroitin sulfate and hyaluronate synthesis in cultured rat liver fat storing cells. FEBS Lett 1989; 257(1): 134-137.
14. [14] Armendariz-Borunda J, Katayama K, Seyer JM. Transcriptional mechanisms of type 1 collagen gene expression are differentially regulated by interleukin-1 beta, tumor necrosis factor alpha, and transforming growth factor beta in Ito cells. J Biol Chem 1992; 267(20): 14316-14321.
15. [15] Bachem MG, Meyer D, Melchior R, Sell KM, Gressner AM. Activation of rat liver perisinusoidal lipocytes by transforming growth factors derived from myofibroblastlike cells. A potential mechanism of self perpetuation in liver fibrogenesis. J Clin Invest 1992; 89(1): 19-27.
16. [16] Win KM, Charlotte F, Mallat A, et al. Mitogenic effect of transforming growth factor-beta 1 on human Ito cells in culture: evidence for mediation by endogenous platelet-derived growth factor. Hepatology 1993; 18(1): 137-145.
17. [17] Haberstroh U, Zahner G, Disser M, Thaiss F, Wolf G, Stahl RA. TGF-beta stimulates rat mesangial cell proliferation in culture: role of PDGF beta-receptor expression. Am J Physiol 1993; 264(2 Pt 2): F199-205.
18. [18] Wong L, Yamasaki G, Johnson RJ, Friedman SL. Induction of beta-platelet-derived growth factor receptor in rat hepatic lipocytes during cellular activation in vivo and in culture. J Clin Invest 1994; 94(4): 1563-1569.
19. [19] Friedman SL, Arthur MJ. Activation of cultured rat hepatic lipocytes by Kupffer cell conditioned medium. Direct enhancement of matrix synthesis and stimulation of cell proliferation via induction of platelet-derived growth factor receptors. J Clin Invest 1989; 84(6): 1780-1785.
20. [20] Pinzani M, Gesualdo L, Sabbah GM, Abboud HE. Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells. J Clin Invest 1989; 84(6): 1786-1793.
21. [21] Dasch JR, Pace DR, Waegell W, Inenaga D, Ellingsworth L. Monoclonal antibodies recognizing transforming growth factor-beta. Bioactivity neutralization and transforming growth factor beta 2 affinity purification. J Immunol 1989; 142(5): 1536-1541.
22. [22] Friedman S. Isolation and culture of hepatic nonparenchymal cells. In: Tyson C, Frazier J, editor. In vitro biological systems, vol 1. San Diego: Academic Press, 1993; 292-310.
23. [23] Jarnagin WR, Rockey DC, Koteliansky VE, Wang SS, Bissell DM. Expression of variant fibronectins in wound healing: cellular source and biological activity of the EIIIA segment in rat hepatic fibrogenesis. J Cell Biol 1994; 127(6 Pt 2): 2037-2048.
24. [24] Rhoads DD, Dixit A, Roufa DJ. Primary structure of human ribosomal protein S14 and the gene that encodes it. Mol Cell Biol 1986; 6(8): 2774-2783.
25. [25] Maher JJ, McGuire RF. Extracellular matrix gene expression increases preferentially in rat lipocytes and sinusoidal endothelial cells during hepatic fibrosis in vivo. J Clin Invest 1990; 86(5): 1641-8.
26. [26] Rockey DC, Boyles JK, Gabbiani G, Friedman SL. Rat hepatic lipocytes express smooth muscle actin upon activation in vivo and in culture. J Submicrosc Cytol Pathol 1992; 24(2): 193-203.
27. [27] Pinzani M, Gentilini A, Caligiuri A, De Franco R, Pellegrini G, Milani S, Marra F, Gentilini P. Transforming growth factor-beta 1 regulates platelet-derived growth factor receptor beta subunit in human liver fat-storing cells. Hepatology 1995; 21(1): 232-239.
28. [28] Ballagi AE, Ishizaki A, Nehlin JO, Funa K. Isolation and characterization of the mouse PDGF beta-receptor promoter. Biochem Biophys Res Commun 1995; 210(1): 165-173.
29. [29] Armendariz-Borunda J, Simkevich CP, Roy N, Raghow R, Kang AH, Seyer JM. Activation of Ito cells involves regulation of AP-1 binding proteins and induction of type I collagen gene expression. Biochem J 1994; 304 (Pt 3): 817-824.
30. [30] Terris B, Bedossa P, Poynard T. No effect of neutralizing antibody to TGF-beta 1 in acute CC14-induced liver fibrogenesis [letter]. J Hepatol 1994; 21(6): 1149-1150.
31. [31] Border WA, Okuda S, Languino LR, Sporn MB, Ruoslahti E. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1. Nature 1990; 346(6282): 371-374.
32. [32] Border WA, Noble NA, Yamamoto T, et al. Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease. Nature 1992; 360(6402): 361-364.
33. [33] Yamamoto T, Wilson CB. Quantitative and qualitative studies of antibody-induced mesangial cell damage in the rat. Kidney Int 1987; 32(4): 514-525.
34. [34] Ruscetti F, Varesio L, Ochoa A, Ortaldo J. Pleiotropic effects of transforming growth factor-beta on cells of the immune system. Ann NY Acad Sci 1993; 685: 488-500.
35. [35] Arthur MJ, Stanley A, Iredale JP, Rafferty JA, Hembry RM, Friedman SL. Secretion of 72 kDa type IV collagenase/gelatinase by cultured human lipocytes. Analysis of gene expression, protein synthesis and proteinase activity. Biochem J 1992; 287: 701-707.
36. [36] Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis. N Engl J Med 1994; 331(19): 1286-92.